0001104659-24-087305.txt : 20240808 0001104659-24-087305.hdr.sgml : 20240808 20240808163035 ACCESSION NUMBER: 0001104659-24-087305 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20240806 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240808 DATE AS OF CHANGE: 20240808 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VSEE HEALTH, INC. CENTRAL INDEX KEY: 0001864531 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HEALTH SERVICES [8000] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 862970927 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41015 FILM NUMBER: 241188956 BUSINESS ADDRESS: STREET 1: 980 N FEDERAL HWY STREET 2: #304 CITY: BOCA RATON STATE: FL ZIP: 33432 BUSINESS PHONE: 5616727068 MAIL ADDRESS: STREET 1: 980 N FEDERAL HWY STREET 2: #304 CITY: BOCA RATON STATE: FL ZIP: 33432 FORMER COMPANY: FORMER CONFORMED NAME: DIGITAL HEALTH ACQUISITION CORP. DATE OF NAME CHANGE: 20210526 8-K 1 tm2421133d1_8k.htm FORM 8-K
false 0001864531 0001864531 2024-08-06 2024-08-06 0001864531 us-gaap:CommonStockMember 2024-08-06 2024-08-06 0001864531 us-gaap:WarrantMember 2024-08-06 2024-08-06 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): August 6, 2024

 

VSEE HEALTH, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   001-41015   86-2970927
(State or other jurisdiction
of incorporation)
  (Commission
File Number)
  (I.R.S. Employer
Identification No.)

 

980 N Federal Hwy #304
Boca Raton, Florida
  33432
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (754) 231-1688

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Title of each class   Trading
Symbol
  Name of each exchange
on
which registered
Common Stock, $0.0001 par value per share   VSEE   The Nasdaq Stock Market LLC
Warrants, which entitles the holder to purchase one (1) share of common stock at a price of $11.50 per whole share   VSEEW   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933(§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company x

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

 

Item 7.01. Regulation FD Disclosure.

 

On August 6, 2024, VSee Health, Inc. issued a press release announcing the launch of its Aimee telehealth service in Wichita, Kansas, in partnership with Stand Together. A copy of the press release is furnished as Exhibit 99.1 hereto and incorporated herein by reference.

 

The information included in this Item 7.01 and Exhibit 99.1 of this Current Report on Form 8-K is not deemed to be “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall this item and Exhibit 99.1 be incorporated by reference into the Company’s filings under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such future filing.

 

Item 9.01. Financial Statement and Exhibits.

 

(c) Exhibits.

 

Exhibit
Number
  Description
99.1   Press Release dated August 6, 2024
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Current Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: August 8, 2024 VSEE HEALTH, INC.
     
  By: /s/ Imoigele Aisiku
  Name: Imoigele Aisiku
  Title: Co-Chief Executive Officer

 

 

 

EX-99.1 2 tm2421133d1_ex99-1.htm EXHIBIT 99.1

 

Exhibit 99.1

 

VSee Health and Stand Together Partner to Launch Aimee Telehealth Service

 

SAN JOSE, Calif., August 6, 2024 -- VSee Health, Inc. (Nasdaq: VSEE), a provider of comprehensive telehealth services that customize workflow streams and enhance patient care, announced today the launch of its Aimee telehealth service in Wichita, Kansas, in partnership with Stand Together.

 

Aimee is an innovative virtual healthcare, labs, and prescription drug service that patients can access whether or not they have health insurance. Working In collaboration with local community centers, Aimee offers a robust telehealth service that transforms numerous community organizations into centers of care. These centers provide virtual urgent care, primary care, and medical weight loss with exercise programs to help improve the health of residents throughout Wichita’s communities.

 

“Healthcare is becoming an ever-larger burden to the individual and our communities in terms of both cost and access,” said Milton Chen, Ph.D., co-CEO of VSee Health. “We are proud to work with Stand Together to expand access to affordable care, initially in Wichita. Our telehealth software that powers Aimee is robust and modular in a way that seamlessly integrates with local community centers and empowers their members to take charge of their health.”

 

Improving Access to Affordable, Personalized Healthcare

 

The collaboration between Stand Together, VSee Health, and local communities aims to address critical gaps in healthcare, particularly in underserved communities. By providing low-cost access to medical professionals, prescription medications, and labs, this initiative seeks to improve health outcomes, narrow healthcare disparities, and support the overall well-being of individuals and families.

 

Aimee will be available for a monthly price of just $4.99. Patients can make a virtual urgent care appointment for only $9.99. In addition, virtual primary care appointments through Aimee are just $29.99, which is less than the co-pays most health insurers charge for primary care visits.

 

“We are thrilled to partner with VSee Health to launch the Aimee service, an innovative resource that we believe will significantly expand access to affordable and personalized healthcare for communities in need,” said Derek Johnson, Senior Vice President of Stand Together. “This collaboration reflects our commitment to empowering individuals to take control over their healthcare so they can live longer, healthier lives.”

 

Aimee was officially launched on July 13th at a local community event in Wichita along with a demonstration of the service, highlighting its capabilities and the positive impact it is intended to have on the community. In attendance were representatives from Stand Together, VSee Health, and local community leaders.

 

About Stand Together

 

Stand Together is a philanthropic community that tackles the root causes of our country’s biggest problems. Alongside inspiring partners, we drive solutions on education, economic opportunity, health care, bridging partisan divides, and dozens of other pressing issues. We can all make a greater difference by uniting on areas of common ground than we can by acting on our own. Learn more at www.standtogether.org. Join us on Facebook, Twitter, LinkedIn, Instagram, and YouTube.

 

About Aimee

 

No one should have to choose between their child’s birthday gift and getting medical care. Aimee tackles the problem of healthcare disparity and out-of-control prices through innovative telehealth solutions. Led by Stanford PhDs who created telemedicine platforms used by NASA and SpaceX astronauts, it offers secure and affordable quality medical services and prescription medication to all Americans. For more information, please visit seeaimee.com.

 

 

 

 

About VSee Health

 

VSee Health is a software-as-a-service (SaaS) platform that enables clinicians and enterprises to create their telehealth workflows without programming. VSee Health’s system allows a telehealth mobile app to be created or a telehealth system to be integrated into existing hospital operations in days.

 

With a focus on patient disease state telemedicine and turnkey billing services, VSee Health has integrated an intensive care, critical care and neuro solution, powered by iDoc Telehealth Solutions, as its initial module for the VSee Health software platform. This technology encompasses a set of integrated telehealth technologies and a team of neurointensivists, neurologists, and tele-radiologists that who treat and coordinate care for acutely ill patients 24/7/365 in the neurointensive care unit (Neuro-ICU), cardiac surgery intensive care unit (CS-ICU) and the intensive care unit (ICU) for stroke, brain trauma and a wide range of neurological conditions. For more information, please visit www.vseehealth.com.

 

Forward-Looking Statements

 

Matters discussed in this news release that are not statements of historical or current facts, including but not limited to those relating to VSee Health’s ability to improve healthcare access and provider efficiencies, are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may involve known and unknown risks, uncertainties and other factors that may cause performance or achievements to be materially different from historical results or from any future performance or achievements expressed or implied by such forward-looking statements. Accordingly, readers should not place undue reliance on any forward-looking statements. More information on risk factors relating to VSee Health and its technology and billing services is included from time to time in the “Cautionary Note Regarding Forward-Looking Statements,” “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections of VSee Health’s periodic and current filings with the SEC, which are also made available on VSee Health’s website at www.vseehealth.com. Forward-looking statements speak only as of the date they are made, and VSee Health undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise that occur after that date, or otherwise.

 

Contacts

LHA Investor Relations

Tirth T. Patel

212-201-6614

tpatel@lhai.com

 

 

 

EX-101.SCH 3 vsee-20240806.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 4 vsee-20240806_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 5 vsee-20240806_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Class of Stock [Axis] Common Stock [Member] Warrant [Member] Statement [Table] Statement [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 6 vsee-20240806_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 8 R1.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Cover
Aug. 06, 2024
Document Type 8-K
Amendment Flag false
Document Period End Date Aug. 06, 2024
Entity File Number 001-41015
Entity Registrant Name VSEE HEALTH, INC.
Entity Central Index Key 0001864531
Entity Tax Identification Number 86-2970927
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 980 N Federal Hwy #304
Entity Address, City or Town Boca Raton
Entity Address, State or Province FL
Entity Address, Postal Zip Code 33432
City Area Code 754
Local Phone Number 231-1688
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false
Common Stock [Member]  
Title of 12(b) Security Common Stock, $0.0001 par value per share
Trading Symbol VSEE
Security Exchange Name NASDAQ
Warrant [Member]  
Title of 12(b) Security Warrants, which entitles the holder to purchase one (1) share of common stock at a price of $11.50 per whole share
Trading Symbol VSEEW
Security Exchange Name NASDAQ
EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.2.u1 html 3 23 1 false 2 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://digitalhealthacquisition.com/role/Cover Cover Cover 1 false false All Reports Book All Reports tm2421133d1_8k.htm vsee-20240806.xsd vsee-20240806_def.xml vsee-20240806_lab.xml vsee-20240806_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "tm2421133d1_8k.htm": { "nsprefix": "vsee", "nsuri": "http://digitalhealthacquisition.com/20240806", "dts": { "inline": { "local": [ "tm2421133d1_8k.htm" ] }, "schema": { "local": [ "vsee-20240806.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "definitionLink": { "local": [ "vsee-20240806_def.xml" ] }, "labelLink": { "local": [ "vsee-20240806_lab.xml" ] }, "presentationLink": { "local": [ "vsee-20240806_pre.xml" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 1, "axisCustom": 0, "memberStandard": 2, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 3, "entityCount": 1, "segmentCount": 2, "elementCount": 65, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 26 }, "report": { "R1": { "role": "http://digitalhealthacquisition.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2024-08-06", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "tm2421133d1_8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-08-06", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "tm2421133d1_8k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://digitalhealthacquisition.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://digitalhealthacquisition.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://digitalhealthacquisition.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://digitalhealthacquisition.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://digitalhealthacquisition.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockDomain", "presentation": [ "http://digitalhealthacquisition.com/role/Cover" ], "auth_ref": [] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://digitalhealthacquisition.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Common Stock [Member]" } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://digitalhealthacquisition.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://digitalhealthacquisition.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://digitalhealthacquisition.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://digitalhealthacquisition.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://digitalhealthacquisition.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://digitalhealthacquisition.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://digitalhealthacquisition.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://digitalhealthacquisition.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://digitalhealthacquisition.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://digitalhealthacquisition.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://digitalhealthacquisition.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://digitalhealthacquisition.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://digitalhealthacquisition.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://digitalhealthacquisition.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://digitalhealthacquisition.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://digitalhealthacquisition.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://digitalhealthacquisition.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://digitalhealthacquisition.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://digitalhealthacquisition.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://digitalhealthacquisition.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://digitalhealthacquisition.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://digitalhealthacquisition.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://digitalhealthacquisition.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://digitalhealthacquisition.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://digitalhealthacquisition.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://digitalhealthacquisition.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://digitalhealthacquisition.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://digitalhealthacquisition.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://digitalhealthacquisition.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://digitalhealthacquisition.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://digitalhealthacquisition.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://digitalhealthacquisition.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://digitalhealthacquisition.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://digitalhealthacquisition.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://digitalhealthacquisition.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://digitalhealthacquisition.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://digitalhealthacquisition.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://digitalhealthacquisition.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://digitalhealthacquisition.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://digitalhealthacquisition.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://digitalhealthacquisition.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://digitalhealthacquisition.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://digitalhealthacquisition.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://digitalhealthacquisition.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://digitalhealthacquisition.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://digitalhealthacquisition.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://digitalhealthacquisition.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://digitalhealthacquisition.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://digitalhealthacquisition.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://digitalhealthacquisition.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://digitalhealthacquisition.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementClassOfStockAxis", "presentation": [ "http://digitalhealthacquisition.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]" } } }, "auth_ref": [] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://digitalhealthacquisition.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]" } } }, "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://digitalhealthacquisition.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Statement [Table]" } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://digitalhealthacquisition.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "us-gaap_WarrantMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WarrantMember", "presentation": [ "http://digitalhealthacquisition.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Warrant [Member]" } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://digitalhealthacquisition.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 16 0001104659-24-087305-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-24-087305-xbrl.zip M4$L#!!0 ( -"#"%GN_63,[A0 $UO 2 =&TR-#(Q,3,S9#%?.&LN M:'1M[5UI=^*XTO[.K]#+W+Z3/AT6FR5 TMS#EH2L-)!.=W_)D6T!2KS%LEGR MZ]^2;+,:0M)D.CTSN:Y=2J=%HE!QEDI;33TG%8C$UYC1Q MGZ@TCJ23TVDI]>WRHJ,.B($3U&0N-E4RK:13\V$]?UXZ)54Y1C8A2[DG'*)M)R0\W-,$HRH"XS@<[)O#9_E4TADI)#/ M2NY@I@C H M6. *WSF63E@DM2A9(-=<)^%.;,*B18'B%"_F=>1$.C-G%M7R3->91.L:%"XT MQ1QW52CXZ2L9L2 M0SD%M5(^RZ/_2R30,26Z5D(=XAZB*VR0$AIKXT/4K(M?[M)R[>ZF\T&NGU0J M+?C!U4&)Q):5,](=U_ENDZYWH:[;L\TVII5>43M7O"/@KJ ,_%LQB*G!?^ZQ MCOMW/:PS\@).]3E.#1,Z95(#5@[6FZ9&QN=D&X%C(9W,9:7NV^2J8O'XG MW05QQNB&D[-Z\S% M@"!*'$CKA(ER'JI+3.1@$ >)Q%H:B#C,QV B'"C),=/B03&/?I_CC!JV3GAD M")I9X.PWQ2S/"5H"(M'MI4!YH>B2\D&\"BF)4#C\=I8*JJUH"T;#&EI*R( H'#<.G9)>29]R&=6MEP+7&5-G;!D2:3Y MUL/O O.M->FQ8QFS!F:_W069\:YF&89E=EQ+?;@DAD*<7V/VF2U)GP^@V?=! MB0:2C&V=JM3UY40:C'M3@--XH$RIXX+9>/6:CADXDU"K,J8L7@Y)5O0]2D6R MGQ,L%2G9/\U1;K$#.-#]1SC)@J[_8 ?Q3.I[!Z3IY2XW"&:>0\I!.B\!2<@J M+%K@SWE%,_>1P3K^@?*"YI4-S.#'RPW&L$V+)Y7?]F,01*?Y6P?/ 3HZ0BF'L-R+!8[LD.P M96"G3\T22L?+__U#RJ0U!4#0'']N>3A(MW!?(>1[#^;42KF674,8& MC!E\H5BN:QG!=R.JN0,.$-,?X@NU%?W:51VK#T@&#,DLG6J'*"@,.?GE MTJR';F5I<]>#_A\L *2-.'B(_8!-9I'[Y2 M(=#PR'S$;&S.ZW0KW4;G2'$ WW4: MM9MVL]ML=%#EJHX:WVJGE:N3!JI=7UXV.YWF]95/=Y12P$I<&,YH5:J@I31O MZ;;2.6U>G72OK_91/5E+(CF=RQ;#VH+13BSV3 <4=M,!2OGXNGT9M"3TYE&( M3X:*Z9R8[242=4OU>+;@<^P[=3H3G[8&C[:1A9XOG+*4)R?,LRW M&2\7$N?+4X2_W. [\GBE#"[9;EQU4;O1NFYW?T,%6I[#/, L@=$$[D.=2ET'1CK ZP"7&GHKH(BJ5B)KM#$ZR5.;3, M&[?$$0Q7JTULRW'17OB98,A7A+F(#($2.:*8:!]+L6F\F8V[]-*X:PD(U/#Q M4?0 K.2,TTY[(%E]Z44#T%\J_1RG8[>D<:P)M ,-3R8@,#$7!ZB4CAJ@"\+% MRQ6O[X&:^7W$F_GE@S:[*_]9[J-JT$?^TD:;]"GC:\\N7U6*[J(ZO=4KN%H= MWA=?'2,E:7599;'M>/EKI]&(G38J%]W3?=2\JB7?OA.BK;;7&(/80EX^!)RI MG @SQ&RB\@F3ABB8U64(P@*,".?CV_B%BQ6=@&2Z#KJK?%LH#M[,/]M8T\+/ M+VYR#LM-(9IJZ3JV&>"%\#>!Y(]<)^0_)(Y+5:R'!@/$%X#](U=;0H-K =^J MQ:?B9.0/.X)6Z0!:+7O_\8+W-TW5M!"QY=;1LE!7B-]'Q"$+?QC$3_.IJ*YT6.-.T MUR0.^#?TE/1AYJ<1['[&!S)O[0/9!1\XICH!8RG$B>[P'T[;:!S4C?.O/Q'] M,JO].6N7K\M(B:R4EG+_]MZSO5=9Z+TN'C>#)2Q5C(Q-7C*2GZ,](Z40 5O!X#>'P+928R*&$I3.?+%#ULDBXJF M.82QX,<%-8D4'6J^]-J#"TT^;VGYUX>:W&JHB1 @7BX6TN@*'8.@#M;1Z6B" M_LBD-TUA$%?47S]:4K<>I6X-?KUVNM;(C%96?SH_;VMF%JO:ZY7-KU5VUGR\ M7+54C-K8MW::0$ @[BU!NLY3Y*"J3W^7GU9OG@9UCM8J_B2 MD/'RL6XY5,,;D\FV\&/A)?+#,VB?N0MK^WA!@G@YD\EFY-\;+ 2*<4A@.^"WU(:@1,9$]5PZY!-J MR&^$10*$7YB/H0<0[X)WD'#?IHG9:LM__RC(TL$A S*=V /+),@4N&F?8SC= MX[$B!E-)#/ZM@85@,.TMCZ9,,)IX;*X Z?KQX[)3-Z-=M?OY@]>/GX45]ODV MX^6#W+I,]W$E%83)_ *RB-[BFF^:+MB7W?OUN6-(L# /\1?H')%OX2/V P]X<0_Y:_40/'CBC.F8 MA4O7;[1,MUM%[ST&TX!)O%P;$$BM?"<"VP @()[RB9ABC9%"=&O$->6%W!Z^ M.(7$>:Q'=1C!B#(8SBXQ-3"#:X$E#$]WL4DLC^D3Q&"*P7H343VH8"G0NC_S M"+8_YE8^/> #)C8G85D/$+HUXO4XLJ%\)L;0'B,$G1"3 ]%8TX2ZGC]+K"3E MI"_SQ]+ONE#ZHM7078*9M9QN02VN&HNOP)U"$.IN'>J"$_#ILF<&$TL6'>^^ M%V[R?;UZJY_F7KT5HUB63K I#F4NA<*%'8!(L?P>+1RNC8:+/YX!"=-!M+N> M"*0&:\R+C>RY;45^/L'WRZR<"T;-TDXBWT#F$_?.K.V732I_S7H[?TZ' _MN40'@WY M86YQ?(0G;N>ZUUN'3M,GD[-TKVKBXLM.KFSIV0L[%NME>_<>#J(GU#G9MXO= M4E9+R'O*1__35D[O5_C7[5\8R)=D>K!UUYD8BJ7_!N+[J]1*^2HX&21L M3\(!$9P<-/V?:#2@4.I/H8E#M*E^$:%: 1GZC@6CC'N9Y920TU?VY'1V7\X4 M]N5<[N.J$ZUSMET']EG,KH7@VY_+3"19$6X8&:/#.RU ONXNR!S-RHVANZ?; MUDW^]%'M.J.'C3'^%;>O%J/]PC;;LF[QLE\=B?K[Z#_I)%^0! =TT!#K'D$V MOW@SV'3T9GWD7]>'&]PW935J_I MY^7M6!ZPHW9BY8.H0#"O>QPB/]/PXQIG\&,$NL3. W'1Q47MF>;SXI\<*[DXL]6]@PBS#?_E1%T7\D*9E+ MBTPQ E;D'Y8OLF^4+Y8\25*^]GIRT6:9S3OU/^5)Q6?RQ.W?ME>C$L7QVR:* MI0Z6K>M&K_75+)[AG7;PM@DBD_Y+$L1;'398639ZRYW+IJGQ!0:"E E2Q2XF MU'J \$?$$=+%W<4890C\"MR!,^XC2(HC=\ CJLUW'#%#&NE1T[]S,;?#DLZA MU8M:L_M9F3U.=W H-EE"6BIN;-C\Q@;?.YY;\)"5A+SEQ2\4"N_D M;[7/O/GB:&.Q7V)AOX3>^S/K?_YAJ+"%$]% S>4O$W%-*5*V>'G\7*#_VW1_LQ&(D2_G\#[300"?<(;'U&("]SW3-#78CVB02_'"%N=[\EUWHE)N CQ'!\FT ME$1MTO=T_V38<1W5*5-UB[^%DOQ=#BA.,]VUB?R+WGYCP6WO??2U0P@Z%:\> M[OM%35-- BYE'F0-/I7G1YH=2%]\[H]-$W(,WVT2F4+'\&$@[D"Y@#]!*"+. MUOJO*")&G"%?" #L>DO5 77Q/CJ'.(OY4463KR2[)G'8@-I^>NOPM(6Z5E] MY22J0*ZUI^?N%B4!Q-GS').R 1>3@]4!56B@7;&8E!"P()#L.,O9#2T@YM]# MZY"TIX_(_6:8E8HI*36GKZ8&QY?]:8) XU,?CG']5XT3HO::YSA\9S1X_8#[ M^?R12FYFCE@T BA(G*94".+'J.7T88_J1!._2X<"K #$L"U&Q 'X18A1B$5 MB_WIO;H1(!G$/.4>*O$VA&M1K%#=GXB(RACBH<]T'T02.P^Z[BM!N;+1>BID MH?-C\[W.3XGZC078=GH^W#\7RM:?8@NF6?O<\[ A$)Q09U5'F%(36]R?)V/A MP?P(*G%C8##P>! GN%:O+L@%UH!QU?-?T]8_]:P'.WO4=\DR#! MS47XHZLC!]MKKG/]Q"[YBXRS8VF^VO@$]R[J_O<5: D"U P"E"3 4@0G1 M&JMNYV,P[5O9W!LM;N[M<%1(_+;OBP+&*SI^9]+6+#"8F!2&2!L"!K@)OQU8 MQRY&XBK_'E^[*^8'\O_SH_?]_QX M[>VW3O/DJM*]:3?>+[1;,YN:?QK/7[=]]*@C0"M;W62)16V*[$('T5 M>WR1=JNIEC^Y8B =U+#\)[84 K.<'I\F\!9$+/<)8GP6Z_'YBV@'>^[ 1=$!<_NWGN#RU1 @:==+C%LDGB[DI M;*0F?_2DA!+!USM&BWQ/'@6/R@7I1KPLMYNK].&AW/1F,!V2;46572+;Q2V" M'=JT.BEMPAI+64I9S%([[5Q:3K$4\M<#A$!-PZ)]P'6H0AE]\-ZC]<3?[HA\ M^F!W;:R88;1X*90W0M9KJLA"[X)?9W @R?@VDOL]@V?^"F4+T3F\3^/?/IW\4A M9^/B??'X47ZJW SL0O\@5;TGSG&U4[M]4M@X\TVE>?;MBX1O!_+CTX/)\M3] MGLW?V*>RDB%9][SP8,OY^LU)NP-4UF7WNI/XQ]%KYV])*;4/G/R5N^Z M>GE^KM'NPXEE*85\JG?.ND-JYGZ<%CK9AV:JE3T;W7_)G>2,LZ]Z8Z3EBK>5 MHM+QK.*GGCY(M2:G6O>T8PQOI,+-PQ/I,+WC6I7RL7*IE,OA7DYN1)_?3@ M52](/7/L%-KUYEG[_.)^^&@5)JUBL2#9AI-N98Y5I9DWU,Q!1\9M=7S[Z;[9 M^W3L=0XN#$*+5_CI2;N^.O]T==/,>!(M_,BHBG=AI.H7W[Z?#0^ZQ,0#;)]= M3<89S78D)V]^ZK2;[NT/;'[-8;/"Y,GY]^)YM7N?;^ANU3C_?Q>:5X.VC?TGN5&M2\'3]0X;?:_3 KIU".I&M30M9/, MPY/9/J!]B=2>BI/)=>7FQ^3Z8O2E?TW5 R.5&[<.JCA5_/+YL^\!*?[GB\2? MR7(-O?S_4$L#!!0 ( -"#"%G VQ]Q\0P .I*]/7KX]_UW,;G^_NOC;HX4UX5@< M/JF#N-65\N):K<4[6TDSB@]&8J:<7CS"0 R]:<=5TBVU.19/'IT^-G-?OS@Y MN+GWRI^=^H7H)L.K3UZ(H#Z&L2SU$H^<7A;AT>G)R].+CX6>ZQ!7>_Y\WW;GWJ\D)4N-\=_-#F_ MZ_4G%??"MIQ-KX>#7]_.+D;B# LM)B,Q;998*I[EV4@K M'%[/Y48 "*)DY]/2.G@1(?#YLD(;\5YGA0YR)/XAC9=^-!S@81UAY M=B[4F MS.S ;+)WN(D6T&1&'-K8%2P(3ZRT"XTL131+-&6U\X\B)$_$>+M9F*2X- M\%%B6>LDK\06+VTFR^$ R*D:H\,FD0".'<]B%PM\ LZ.4#WF7-QFPFE]8 M!PB9IE+.-EYL)[5N*8W^Q.MZ; Z\D=9AV,(@$W%;**^PD_0\X;JS7>.66RS6 M3L,=FPZ9N:A4KG$2L5;$Q3@6&8D.J#XJEVFO:,*E(XAC\4*5M= 5K:$8R.E( MV Q\@65A;HH5'&-9V":T\'WL_(?&OM@>32N_?RA]7.9TBM<=&@FQ)6@ ,*@?"_ZQ&?!%UFX2DOA M.-H!X-6W M!@,_J7PXV,)W+U,,T-T]/IZKL%;*W /RB..@/6XDNUW84-Q)'8E-YKDCRT%. M O/A4M8)ALDGR!+&%,T(P,X[+>OB MK04>:?*.'^T*6GR'F3_MGI0/J-4^Q1]KI%?JCN=L:;FEY"9@3V1<(YU#IK(] MR7"0:X_#\&[CW+ZI:^M8$ 4F<8AM2$)9CN>*SD")2D=@, PD%X*;)LZ-N<%^9^Z.)QEA-VTJ!OH\[.J+I1DAIP+^D M1"6#"RDH>Q%Z4,N-QWGP;C^[(3),)$@[VUEXI3T2TOUS::=R(NJ-@W,YX6Y3 MY2@;/65D84YI.)DK&C>E9J-[>2C"$H+=IFQK!=P ^JL$(H^]Z 5BU00X^6OB MR4EKCXQW8I*<<2\E,$KEN\I_KIRZ$[_:PGA"STP9C6&_$51OV@R,HO5>0="F M ;=$'KOLZ=2B5!EPUJ8DFG'']DE22@S0#_].2N%#9TLFC*2VVP-!_F-Z39%2 MDA5+:Y;$R_$=C3'TV.^M\B8>D92TP?TQ'XJ0@FMAVE^;U0 *% HD4MLR1X<7" MV>I!Y15?%EY824F2SOTC&F1;TSD5-KM'WLM,ZE[B3]6WJ N(H2')J776W.]7"JH#_(2L%^%Q&A*V":6(BFJ M-3-+V\P8$;'FCG,:6S:QY 4F5=[$-&@D4&H9%%O9<& Y7>&]M8222I.YT_FR MG5=[D \35YOHY/:3,G''?&I"L^?P\;ZAW.V]BOT"$'O2]Z53J#P":=HLL15#HB-]:B0A7C$"ELBC%J_C?!B!V.-#( +%VI4V=RJ_-%WC"S-0O9YZ M)+_;YK:9JSV.-*;9O0RP:PN? JJEJB;H/XR;P-G.)@C M*RRH6;C4BU@B Q",GK9RB+V?U#GLA66*-0)C3XO;?'^3F@]A;!?C5KXYT^WR MS%[>@X#O5_,I)@FU.>&9^(-2&W%3G%-G#4?C2,FY"< ;U3A^7J3^)20$#BE1$V!>'=K6F5=9XSAG I*W.=0'I"!TD-80;8M6?-81 MW!90G(8AH*<5G(=HQ!E>(6WBN--TABH13 UA\BD-ILI*DGTGB.KO.'X>;0/C M+^.Q>*55F1^C4%FJ%WC_0T.$A6G%>)QNCT[.+W_;O>D9!UOCE:,ZM'./YS8$ M6QV+9_0,R2+DNGOVL@3@Q"$6!RATC@U\?G-$/?SM04\.L.8#R\\!F#O4F' ! M]ECSGOM;>O; CFB;_^V2/<,^(\S*6<_#0<3*2QFB *2YI3:4<)OVW@5*"!:C5"2T+)2(M<=@[9U- M["&2,5-KF]JWD[YENPS&;WQ0%?BGY'&R/UUED6ESK4Z+SE7'?MQ&Z#,G3Y)> MZCJ9>6SGJX_:,[$7%@E1 *%95(A=PU] !/8P37X?JY>%S6+>TMZ(08>88)&C M!+4C$S%;"8U#-K-!YEB69)26W'=*"BBI[]N1:_60+N]B$MBU\6([!3,;U3C; MB=@HMJ.C'.ESF_4N8(>#62MU2!D]UU6IWQT;U;%O0F+;WU37[6XA2SX@/G&,B85F06Q:T.^8$-Q!RQK,!96@5YV-VA'3P_^ M>O#SLU_X]I%.OK.'-)HR8O'C-7TSOCS[YT\C>IQKF0E/K3&W$0\..)OQVUVY M^N!+_ 9MCU*%.X7D=NXD[<7)II+QH@1AC<+"21/;^YU-8NEI8L?MSTD_9>(K MZ'^Z&_B^$X O2P9."DCFXRN4#!1.,PH[[BKNI7:\H68$,D.P"'C%,X7&?KA1 M8&>GH@L9Z-Q2HRM>WYV96>)BL;[MG/(0XTN-25 M#K%% L7PU/Y =-,;>/*08,3NR^;S?GSL\:6N8$Q5T^\/%#>/P VQ&0]#=XI%=9HQ M!1T^?_X+A\47EH-S*'97ML1Q[@PJ5SY!8^*_(;QWV#G]QL$%!&77?(H5-AG7 MNL0_-!,W#:@/RM&'4:BAB7<*:JFFGC=K945E=VRKM;5WB VGGAN1\3=9KD'>W^ M5=Q]^Q7M+'W]1AKDXC2RBY_S&-K:1HA-C2PW7GN^AWD%I3+49A5G+9OS2^]: M!"S$VRYWZKKF*DN=I,6# 8L!VB(%B7K8\H$FPZ6[9C+*[.(L7;3$:W19>@MX MYOWK(^SFH076:@Y%Z?H[]U3E:U'G:Q1'\>8H=I=H)WE*;3=Q([2'*/A]0/#% M)+7HP8Q6V'F9 I\O1!I\S#!G4_-<@+]3*_JAQ]; Y.)8*U;;K89#"WD(O"U 1[01D8[+W['KU M5%R:E2*" [3+".=OO,XM]9?$+=]GJO(;3GQT>#0^>G(X?O;L\.DWG#;4M,^_ MEX74%#;?-3C^1#/FZ 68BOUZ+*ZD#]]/;^;_UR@YH!\JQU\NTP^<_P-02P,$ M% @ T(,(63%XH3I- P 0PT !$ !V/>?LKK0KT3R=1!0]@Y"$LY93K?@. A;PD+!AR[FY=L^NVYV.@TY/ M/GY ^M?\Y+KH@@ -&^B MYZM?CQ,5?3WH]Z)]]L+9'WDN!B_MNU=\5/,A:&G1TY*5>"RTA)WU!K73=,^X^EE H M:R]9@R=,*LR".7RH"L(L>,_+G'-0LA2ZGT&)A8:P@),05(;\V=,.C:_5+3"1 M[A#CN /L.RGHKEC#BR%*@.U<1'DJI<8Y%)HYIHCA$HL$.9V3;L]XS: J1KAX"DADB@],::[#?>+?^COZQFE$ %3%UQ$YS# M"=4E/268D@&!T$$*BR$HTZXRQL&VZG8&,&-VVN[Q\'D;#E9,L9<2L?PH"PE'>2SVH5N68R$[,->IDR MF]XBN*R42 BOV$FZC@5(34]+[&I#SL\AZ[D!ID%"=Z).\UO'S.UV8TL[;D>V M!P.4CGK#]%?+D<1GI&BSN5![82 M6 0EE=)5I$5X#$(1/3DS]TV6.E&&_F,F##)QI(.\_U@YQ?UM*]<4H.]8MNLNVK76^,=^IX/,B2+GJIC=_O^COQ3NHJ0OG0B%6NMS6O5+9^]KE02JU MAF*^7,MSC,*4>-FF$68I M]F.WTYC^M]KL("P^.P3S=VO7L#MT03GXLA9H>IF:7OX%4$L#!!0 ( -"# M"%D-3B1;VP@ &MH 5 =G-E92TR,#(T,#@P-E]D968N>&ULU9U=<]NX M%8;O.]/_P*K7LK[B[<8;=\=1[!W-)K%K>9.V-QZ(A"2,04 +@+;T[POP0R9% M'))*;9CTA2U1!\2#]P5!'!*4/_RZ#:GWB(4DG)WW1B?#GH>9SP/"5N>]/^;] MB_ET-NMY4B$6(,H9/N\QWOOUGW_]BZ=_/ORMW_>N"*;!F?>)^_T96_)?O*\H MQ&?>;YAA@107OWC?$(W,%GY%*!;>E(<;BA76'R05GWFG)^,)\OK]!OO]AEG MQ1^WL_U^UTIMY-E@\/3T=,+X(WKBXD&>^#QLML.Y0BJ2^[T-M\/T)RG^@1+V M<&9^+9#$GM:+R;.M).<]4V]:[=/DA(O58#POW\_B#_-0DN1VX6@61V308:SW[/^-%#[ OG@TT'R83Z45.PZ!RW) MF8Q;\IG[2,4]I);( R/,NWX6UC>;^J-Q?S(ZVH,"!A)^AV(+SM0"MSL0WS3V-*U_K70@_6N!^0$+, M3/?O>6E%^;;N]T*8T@T/!VG,P+J#U^?>5]8/>(C(D=#ET@Z(XYKZ(0X7QNZC M<(M%7Y\547H<85S@];D85Q?'HF5EG/9)O$0153_<*;/B16:]F;!XA/FLWQ:X M\5;I\Q .,G*SPQ\=IQ11IG!ZUAEY?7.*BC2;TB^3R!0K Z/<+]!0,SYS4991 M9NU?(KF(18AD?X701@LZG@PP53+;8L;(22QKNN'>G!BQP="MQS/]4F854+3 M-*[V/@VVQ0[>EOH.+9Y[5@5Q&G=(^VS^A62QK7I M+H]7YD5&MA0\K)4RE8U7MB"OK0;I>5P$6.A9W?"9A7*)@_.>$I&ER8X-FE(D MY?5RKKC_<+$E37I7NP[$@(Q56= (>S>=IBW2?PR+3A@ MO8CP$OLG*_XX"#!)--F=WJ-%91V2C[A_]S8"UT^D;*"0MB\R ML-1+>Z%A @-T1='*KFTAI-7BEDE?==9SA+J?L/0%V:C<# \0.1?9#:T/@<'! MPNU8<8M71"H17T?<-ZAZ\+ 6:;4)]>3@Q,6M&Q>,18C>X@T7-2;D(SNA?0D8 MDOR=6\G_%2&AL*"[)JH?!'=">!LSI/VIXXF*GD EU^":B'\8W0GUK="0_#^Y ME7^^QI2:VWZ(->K]Y?A.6 !@0R;\X^U,N'PT$P7=M.8^[(MTSHHB.>3&SV[= MN,&"\$"W233PX2"X$P[8F"'MW[^%]I2*:)V9NW9UPBX+JS##J-:K;<5%M394:*;0&67/I@RR^NJ MM"Y&=D!O"S"HN:,$-P&;:GR!Z(P%>/L[WE6)?A#: =5MQ*#LCA+;A.Q&D!") MW9SX]0/+86P'A+C=#8A MG#&?BPW/7>^>\D@?M;LI#RI/ 94%.V!-/3]HD*.<-^&\" *!I4S_F':-JFRQ MA'? #(@:O 'F*/^%Z,;'63#NI 7C:@L0X"R:=M&!2;8&C++A -]4O MK\4=?P+NO@/!W9'_@!D4WVD*G++%K;D6-X(_DN1!GSH'#DITQP8;..B%TS0Y MZR?)=*')49!$=D?[/#"HN=,T.06[X5(A^E^RJ9N=VN*[HW\9&W3!4=:<]@AS M&05:=E4(:;7695)07D>IL3GG7 B,X&Z=CVBWN(>@H+:.\MS/W-S567-6>0WY M,*K5&EMA09U=I:OFN3H)#@_[CUNM;)$2DO1E'E6HE_2[($KSF"7\$4NO( %W M_JRAK98:)@9E=Y1RSCDEOE:(K;[H=@B"J%WS3,L+B6"]*I;KDB!T>],51RCG' M?J0'RMUHO+@S#YL#(]%!5*MUM\*".CM*,[_R.X',=^?,=^&"4_@1'DM@J]6& M>$'!'664!2J[U(605HM<)@7E=9119@?9Y=9?([;"\(H.6V2KQ0:!0^,/[$Y1I(S'"2)1=7="J!(JQVI)P?M<'KG]!NG$5-( MQ$MN!7!L6$,[(+^-&)3=Z4W2=%GY_LR5?%5GE?KV$ATPH0(<],+IS=,94U@@ M7Y%'_ DIE/)6>6$OT0$O*L!!+YPN/(X/U*ENSXI7KQTH!'9 ^3(O*+C3]<;S M$%'Z,9*Z ;)R_"D$=D#P,B\HN-,5Q9;[$;$'$6V4O[L1W,?8W!B2^V.R M0?+5: <=L*=Y.T#CW#Z*^_Q-J?,U$EA>1RK^[RF:MO+"146Y#MA4BP^ZX_BK MJ.3S(WLX^+B[Q4LLS.*-.[Q5'W5%#]63J]KBK?;JN%: EN52[P^#@P;JZA_T M9^EV\\O\NQ>]Y7]02P,$% @ T(,(6?K2'9^;"P 38\ !4 !V-@SL@NDYU$/Q9Y*2Q:,/ MOV[7&7HB/$\9/1[M[[T?(4(3MDCIZGCT938^F9U>7(Q07F"ZP!FCY'A$V>C7 M7_[X!R3^?/C3>(S.4Y(MCM GEHPOZ)+]C*[PFARAWP@E'!>,_XR^XFPCM[#S M-",+YD?;/#T> MR>.6AWT^V&-\-9F^?[\_^R]AT&@0OYO7,G&0L([=DB50UCXJ71X%2GDH21N6V>TZ6;C,9YQ,9/Z%DA0NR MD :;D=YM7Y&WG?%=G/\S+?IY\K8SW8C\O]@N;,NO M/KWN\YK)C9?B4\LBV19B ".+RJ0LHJ,'5D=0 T-9=ETZ2UKE9K(W9]RNNQP9 M59E+G,]5P9M\O,+X41Q@>C A69%76\9RBSH)Y88?O3[*P %2D)>,D9QN>D%>U<;,V0\]JZ7"=B0@Y82-T_&4V^D7) M$%LB)43?I?3?'R:[HH.P)*9]:T:5I<]D/2<'Y[LQ'>H9 M2U&00:9ET#FR*$4T.#AMF3S4(O1=R2("0LRIR(7XV#L):0B#@&$9=<)1J^(# MQ+36 8F4(J7]WY*2DV1OQ9XF"Y)J2,2''1OB/S\^L62C:!8E&A6R=_O@ #(E M6]_<%[S- 4-F2U<2)#6>&_A$''@A#WZ>X97#OK'?5Q,[;55MW-H912.[')FM M7&N0%(5JYD\D3WCZ*.]-=M6C)?/>Z Z35MLW-'$A8!N#26AH W7LMV25Y@57 M-ZOK$:>C&P/TOKO^3MOF6. 41P'-$(?@:-$,0G54((Y.*-W@[)8\,MZ%3UOF MFQJ721.6IB8J1AS&0#2T%FEQ("+^OL&\(#Q[Z87"4OKF K!JHF'(HJ+#[0T$ MI):'9>2.8YJGL@/KA<26>K_< ,Q:EQZ&+BI. '/P)4FM#TO*[)YDF7RX =/^ M#L4E]DT+;-CDQ59&10QH#V1&1: R)!YLSI[D[%Q,DP96MJ$/"8]ENXN?6APM M0J;#@12I,"3C I'4>*:BAR%+Z9L>P*K)C2&+BABW-Y 5+4=*'QZ2,[H8A$BM M"P.(8=.-1RF*$(ZVLSXTA#HD&.=IGN!,>SD7V\R?5WJTO@$![9J06,*H0('< M@;#H@(H9%1(4F'\2S(?ATE"&@<6RZD:EED4(BNFM#Q.I#P+)Z8;SEFMXQ(&E MOC#I,UMQ NFB *7'G/4 D):W0 DT IW1(BU>Y.* JXWCP1^WQ!<;D+F*"7-_ M%"P IDP&M Q)'=+"("U?_4I "[DB ZR.*?-+@-MDFX*V)B(2G,8 &G9:M4 F M"!&GHF?B.+N@"[+]G;R ];)T?ID ;+:A,$014>%V!F!1BI%2(R$/ L8-3]>8 MO\S2I&>HL(5^T8",MMDP51'! 5@#Z"C5:'9Q&G(DNG%;#R6@ MWB\L/;;;S #BB-#I=@@0)()0.RHD2!_T,RF(R47)J@ D2PA"W,EB(4Y47OYSF5*R#];? MJ?5+5X?=-E,.840DP>X ?DKEN^H#DC'HFL8"S?0559V&AV8Z%)IIU-!,WP+- MW3.+!)J#5U3U(#PT!T.A.8@:FH,W02,:/FA?+#Q?+6Q\L,D#.9V1(2$S4Q.J:WW#VE-($GC)#\B# *:=U!C:^-!Q&^SC MIYX05W%!^QH]*>_]DE2R,+U,VZ2[B]&:^"!I&^OM7+0Z)!(W+"]P]J_TL?-" MW"T.@H?3L!.2EC(^5%SV^H#1,4@$A;BP+G&5/V@XEY(9^[W]VNRR5?_$W-P9 M!00N1W8V"7WW1(M\-[-DE!,,] CMW=X:V6&J;N/&OCB:V#9DM;#Z7@M-B"^R M3%67W=PS"C\@8$M\M31DKFIM[NN['/V\AN MVJD'\FI'%*UKNK&&Z6J_Y];\QM-"'%GF'MK0\E<>UW.#@,Y7*W?:K%K<*8JB M];N<66E_M!:UQ9ZQF+$L3=(BI:O/XN*3I]A5*Y?(%Q"PP8H&6Q$%"J M*Y-+ M+425TC,$-YQ("(EH"+4(4&9)Y-?+I7.T[Q+[@J+?< 4'K(P"DEY[)BPB8)PT M(I .02HF+#87>;XA_%7P.$("(02:!T"R]#'B!)GLA4H'AF1K1I*-&!]?]J?S MN[2PDM"Y)=[&),!2$ MG6K?4'18-OEP2*-"!?8']AEU"-K%^,YHJ5*G1Q\'0,),63CJLRF58!^Y27?J^E:X?P/A&LNQWRI[IC."<4;+0]U)< MOQ1UZ_T^,=-CN_W0#"". JB9 YY<%L3?A* M#&^_WA*5Y+ MY'EF[#!H3(P;BB@8 6U!T^+FNP+"Y,[;S+,T.<\8AN^RM#2>,^;9]HQD>3M! M1 38KJ 4>4J(E#)(^W_$](%O'HODY8:SA!#YE%5>]U9]]]\&1OMEYE55:M,T M*#0BSE[C%R!P5P1JE/&N,6*%O)G7>'/][!Z+$WB]*7(Y@@IC\%WPSB#//R\, MJ(#Q(T-'1$3H#; )_>"@(I$*?8=T,&I$![H^RW=9 ,GBX\LM61(NUQW,*8T"L[ZNWP=4Q+^9Z Z. \+5NH4N]'#4+0'/YC%A9!/HN"T&J%-?[ MRYN;+L4GL;G:)/Z:XYR(+?\!4$L#!!0 ( -"#"%GT\:E1)0@ 5C 5 M =G-E92TR,#(T,#@P-E]P&ULU9UM=]HV%,??[YQ]!X^])CRU79LF MZTEHTL/I0[*0MMO>] A;@$Z$Q"0Y@6\_R08"V))OMI7K]45"X,J^_]]?%KZV MY)Z\6_(@U9T^BN4,ML&A(2;5FZVU%^W5O[SY"6?B[MC]&!%-(\M+Z..%9J<-M]_5 M;A]Z1U)-6MUVN]/Z_>.'83RE,])DPG&+:6/=RFVEK%WGU:M7K>S3=6@ADV>YVC MA4X::_@9024YO:'CR/VV[FWVFK ),X1/*>%F2N*_4J:92\L9V'+!K;ZT'=1F MGFUFJNCXM'&OJ=M;]UG[9?N%V]?/.T%F.;<=53/7SQI1:R>/N:*:"I-)_V#? MV&E"%\9V+YJL-^3V_T\S-E,[MO^S*/7"6V3HW+>"<;[AR2 M>]+7O3WS0=/X:"+O6PEEUH]NS[UP7'H9$_O'MVQ'9R-M%(G->DNN.;.PJI@W-+1LZT0J*KP/VX M_6RW[3U3NYD3%:\W;%_N>%OLV:N(UIPHN[UF/&5\TRW&2LY\^%8[E,&LI4JH MLN-MNXW.VQX#=&!?:@#SK5AD[AZN8?A;Z:\,Z-; @#XG6E^-AT;&=V<+!O&A MV.3_:$=1Q>:PP#)E.Z6WC??0^F5M]!,> KT0I(DP5_+TP(/@>.OA2>?\I M].ISL_7YX*W=8OFIV6X$$.[W8NL_95BS+62,@O7,[C]Q.5QR,BGGNA<"!-M! M)5LJ"POM6ZICQ>8.4 7AG4CL/^6$F6HXDL(\D(PD/KS6E#W M2,4Z*['G1_D%+@CY8C00_8M:H/>)16(_G%+.W75R(D#]OBP>R/^76O#W"ZZ! M Q?W[F3 JH&;L-4$Z,/+VOE0D(UDQ3553"96A@*84 @&XG]5"_P>J:C@+T0" MQ;X)!1=4-:*^IQ.)^273,>%Y1I?VO;++P5NIEX1#V>-6LY5Z4?G_08D"T]\* MAK+'+7 KM!Z8?#]5:B>9X(#CCX:RQRUMJ]0>&/Z%,,PLW;R,3ZGG0J\-*T9! M8>.6LSYU*)#7%S.$$^7(>*%4"AR MW.HUJ!.%^;5B,Z*60Q97CR?%6"AUW)HUK!0%^RU9#!*;-ANS?%)7-7UO$Z@) MN 4K2#>*%P,12S676U>M^S*U1^BR+Y/@L%_1$.H+;B7[! 8H[IPEB>6F5[^< MDD[(D])P\%VL&C@1T%L3_MVG\>_"^>-6N)5Z:\*_]S3^/3A_W"JW4B\F_[Y] M>:5NY8/G]KDW&,H>M\JMT(I)/LO_2ETK><_R&?%5^ LMH![4H?@-JT8]!/(S M DC_7T="P=>A$"Y7B0G\6FI#^)]L7G4B6AX/A5^'DCBD^-"7-_,.X*Z+^.9* M[85 0>-6P:6Z#LW66:TH\7?HW0@H6=S2MDS5@<%^D.ZFS%2*X&7A8A04,&Z- MZE-WZ,'9+3;3WE%AZV/PI#W6[@>4*AG'$+ MRZ#. S,?2LYB9IB8?+29*T9X.?"R."AMW#+2K_# J*\5=993>_J>S5AS"U75 MU7CL&YU#\5#TN%5DM6)<"P9:IU0]U8B25E [< M*J/I##T$T3NV(N.QT1[=N MR;5G "I$0:'C%I,^=0>&_$G>*N*>"C%.6C@&-!Z:]DTE3 MAP0YGSMOC[&K$6<3XE^?%VP 7JM4"_0!S8=>'IDMFW(/%U*S+(]+^Z*Z?D@YFNUM"&J'L:0.G789YO4#.."XO'I?SYJL*@!271 MX$=&U(&_5RW6TU'BV,T+R;_V14*4!W\H'FI /1:P^A4?V((K,Z5J^ZPK2\:E M'YK#4=T*:@=N(0Q5C_-%O/54A>#W\$X<%'P=2MXRA3@+T-(19_$EER1X?K\3 M!@5=A_JV1!\*YW,B[E0Z-_'R6LF84G=?1V^./T"%!=P U)LZ5+Y/8H)S1>+Q M<:/#J56OKU*3/=O?YA>\+A%L!_6H#D4QA #2N9-^7#5'D_/E#1U3Y29;W-*% M.;<[N@N?2@&:0XVJQS.AP#Q*_#II%03:7=[93U>?N!_N_RRP[_P-4$L! A0# M% @ T(,(6>[]9,SN% 36\ !( ( ! '1M,C0R M,3$S,V0Q7SAK+FAT;5!+ 0(4 Q0 ( -"#"%G VQ]Q\0P .#DY+3$N:'1M4$L! A0#% M @ T(,(63%XH3I- P 0PT !$ ( !0R( '9S964M,C R M-# X,#8N>'-D4$L! A0#% @ T(,(60U.)%O;" :V@ !4 M ( !OR4 '9S964M,C R-# X,#9?9&5F+GAM;%!+ 0(4 Q0 ( -"# M"%GZTAV?FPL $V/ 5 " &UL4$L%!@ & 8 C $ ' /-" $! end XML 17 tm2421133d1_8k_htm.xml IDEA: XBRL DOCUMENT 0001864531 2024-08-06 2024-08-06 0001864531 us-gaap:CommonStockMember 2024-08-06 2024-08-06 0001864531 us-gaap:WarrantMember 2024-08-06 2024-08-06 iso4217:USD shares iso4217:USD shares false 0001864531 8-K 2024-08-06 VSEE HEALTH, INC. DE 001-41015 86-2970927 980 N Federal Hwy #304 Boca Raton FL 33432 754 231-1688 false false false false Common Stock, $0.0001 par value per share VSEE NASDAQ Warrants, which entitles the holder to purchase one (1) share of common stock at a price of $11.50 per whole share VSEEW NASDAQ true false